Trials / Completed
CompletedNCT00818181
Open Label Safety Study of a Birch Pollen Allergen Extract
A Multicentre Open Label Safety Study of a Sublingual Specific Immunotherapy With a Solution of Birch Pollen Allergen Extract in Patients With Clinically Relevant Birch Pollen Allergy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 73 (actual)
- Sponsor
- Allergopharma GmbH & Co. KG · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This trial is performed to assess safety of a sublingual birch pollen extract.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Biological: AL0206st |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2009-02-01
- Completion
- 2010-08-01
- First posted
- 2009-01-07
- Last updated
- 2013-03-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00818181. Inclusion in this directory is not an endorsement.